Brief: Astrazeneca Pharma India, Sun Pharma Enter Into Transition Supply Agreement For Dapagliflozin
28/05/2021 09:36
May 28 (Reuters) - Astrazeneca Pharma India Ltd ASTR.NS :
* CO, SUN PHARMA DISCONTINUED EXISTING 2016 DISTRIBUTION
SERVICES
AGREEMENT FOR DAPAGLIFLOZIN
* CO, SUN PHARMA ENTERING INTO TRANSITION SUPPLY AGREEMENT
W.E.F
MAY 28
* SUN PHARMA WILL CONTINUE TO DISTRIBUTE DAPAGLIFLOZIN UNTIL
TIME
MUTUALLY AGREED BETWEEN PARTIES
Source text for Eikon: ID:nBSE7Bc9Pr
Further company coverage: ASTR.NS SUN.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan
India's Astrazeneca Pharma logs worst slide in two months on quarterly profit drop
Brief: Astrazeneca Pharma India March-Quarter PAT 448.8 Million Rupees
Brief: Astrazeneca Pharma India Recommends Dividend Of 36 Rupees Per Equity Share For Fy2025-26
Brief: Astrazeneca Pharma India Receives Permission To Import Durvalumab (Imfinzi) For Additional Indication